U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H19ClN2
Molecular Weight 298.81
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLIRAMINE

SMILES

CN1CCC(CC1)=C(C2=CC=C(Cl)C=C2)C3=NC=CC=C3

InChI

InChIKey=HZNVLDCWAVIXRK-UHFFFAOYSA-N
InChI=1S/C18H19ClN2/c1-21-12-9-15(10-13-21)18(17-4-2-3-11-20-17)14-5-7-16(19)8-6-14/h2-8,11H,9-10,12-13H2,1H3

HIDE SMILES / InChI

Description

Cycliramine is a substituted piperidine derivative discovered by Schering Corp. The drug is claimed to have antihistamine, antispasmodic, antiacetylcholine and analgesic activity.

Approval Year

Unknown
149124
Name Type Language
CYCLIRAMINE
INN  
INN  
Official Name English
4-(P-CHLORO-.ALPHA.-2-PYRIDYLBENZYLIDENE)-1-METHYLPIPERIDINE
Preferred Name English
cycliramine [INN]
Common Name English
PYRIDINE, 2-((4-CHLOROPHENYL)(1-METHYL-4-PIPERIDINYLIDENE)METHYL)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1618128
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
EVMPD
SUB06846MIG
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
SMS_ID
100000083748
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
PUBCHEM
22017
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
CAS
47128-12-1
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
NCI_THESAURUS
C87479
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
FDA UNII
N61YTN00CK
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
INN
1622
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
EPA CompTox
DTXSID50963752
Created by admin on Mon Mar 31 18:19:50 GMT 2025 , Edited by admin on Mon Mar 31 18:19:50 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of CYCLIRAMINE
SALT/SOLVATE (PARENT)
Structure of CYCLIRAMINE MALEATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966